 Jesse Hinckley
Concepts (121)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cannabis | 10 | 2023 | 509 | 3.140 |
Why?
| | Marijuana Abuse | 4 | 2026 | 213 | 2.140 |
Why?
| | Substance-Related Disorders | 6 | 2024 | 1102 | 1.920 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 2 | 2023 | 429 | 1.130 |
Why?
| | Motivational Interviewing | 2 | 2022 | 121 | 0.780 |
Why?
| | Fentanyl | 1 | 2024 | 128 | 0.740 |
Why?
| | Hallucinogens | 2 | 2023 | 111 | 0.700 |
Why?
| | Substance Withdrawal Syndrome | 1 | 2022 | 185 | 0.630 |
Why?
| | Fluoxetine | 1 | 2019 | 56 | 0.560 |
Why?
| | Adolescent | 17 | 2026 | 22530 | 0.520 |
Why?
| | Marijuana Smoking | 3 | 2023 | 249 | 0.460 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2019 | 303 | 0.450 |
Why?
| | Blood Platelet Disorders | 1 | 2014 | 10 | 0.430 |
Why?
| | Depression | 1 | 2019 | 1546 | 0.290 |
Why?
| | Comorbidity | 2 | 2023 | 1661 | 0.270 |
Why?
| | Legislation, Drug | 3 | 2023 | 73 | 0.260 |
Why?
| | Humans | 23 | 2026 | 145475 | 0.240 |
Why?
| | Mental Health | 2 | 2023 | 793 | 0.230 |
Why?
| | von Willebrand Diseases | 2 | 2016 | 28 | 0.230 |
Why?
| | Thalamus | 1 | 2026 | 129 | 0.220 |
Why?
| | Siblings | 1 | 2025 | 196 | 0.210 |
Why?
| | Antisocial Personality Disorder | 1 | 2025 | 121 | 0.210 |
Why?
| | Child Psychiatry | 1 | 2024 | 36 | 0.200 |
Why?
| | Craving | 1 | 2023 | 40 | 0.200 |
Why?
| | Bipolar Disorder | 1 | 2026 | 282 | 0.190 |
Why?
| | Gray Platelet Syndrome | 2 | 2011 | 4 | 0.170 |
Why?
| | Tobacco Products | 1 | 2022 | 84 | 0.160 |
Why?
| | Vaping | 1 | 2022 | 74 | 0.160 |
Why?
| | Cannabinoid Receptor Agonists | 1 | 2020 | 44 | 0.160 |
Why?
| | Electronic Nicotine Delivery Systems | 1 | 2022 | 110 | 0.150 |
Why?
| | Problem Behavior | 1 | 2020 | 101 | 0.150 |
Why?
| | Drug Overdose | 1 | 2024 | 374 | 0.150 |
Why?
| | Substance Abuse Detection | 1 | 2020 | 110 | 0.140 |
Why?
| | Conduct Disorder | 1 | 2020 | 158 | 0.140 |
Why?
| | Empathy | 1 | 2020 | 181 | 0.140 |
Why?
| | Alcoholism | 1 | 2025 | 822 | 0.140 |
Why?
| | United States | 4 | 2024 | 16098 | 0.140 |
Why?
| | Chromatography, Liquid | 1 | 2020 | 450 | 0.140 |
Why?
| | Analgesics | 1 | 2020 | 231 | 0.140 |
Why?
| | Longitudinal Studies | 4 | 2026 | 2953 | 0.130 |
Why?
| | Dronabinol | 1 | 2020 | 249 | 0.130 |
Why?
| | Tandem Mass Spectrometry | 1 | 2020 | 572 | 0.120 |
Why?
| | Adult | 5 | 2025 | 40777 | 0.120 |
Why?
| | Child | 4 | 2024 | 22707 | 0.120 |
Why?
| | Cognition | 2 | 2024 | 1266 | 0.120 |
Why?
| | Suicide | 1 | 2023 | 728 | 0.120 |
Why?
| | Pedigree | 5 | 2016 | 515 | 0.110 |
Why?
| | Emotions | 1 | 2020 | 574 | 0.110 |
Why?
| | Female | 11 | 2026 | 78845 | 0.110 |
Why?
| | Lipids | 1 | 2020 | 707 | 0.110 |
Why?
| | Analgesics, Opioid | 1 | 2024 | 1149 | 0.110 |
Why?
| | Mutant Proteins | 1 | 2015 | 105 | 0.110 |
Why?
| | Prevalence | 1 | 2022 | 2865 | 0.110 |
Why?
| | von Willebrand Factor | 1 | 2015 | 85 | 0.110 |
Why?
| | Genetic Research | 1 | 2014 | 17 | 0.110 |
Why?
| | Protein Multimerization | 1 | 2015 | 204 | 0.100 |
Why?
| | Spastic Paraplegia, Hereditary | 1 | 2013 | 12 | 0.100 |
Why?
| | Myelin Proteolipid Protein | 1 | 2013 | 61 | 0.100 |
Why?
| | History, 20th Century | 1 | 2014 | 328 | 0.100 |
Why?
| | Proteomics | 1 | 2020 | 1188 | 0.100 |
Why?
| | Family | 2 | 2015 | 682 | 0.090 |
Why?
| | Male | 10 | 2026 | 72843 | 0.090 |
Why?
| | Colorado | 1 | 2022 | 4554 | 0.090 |
Why?
| | Cytoplasmic Granules | 1 | 2011 | 60 | 0.090 |
Why?
| | Chromosomes, Human, Pair 3 | 1 | 2011 | 43 | 0.080 |
Why?
| | Hemorrhage | 1 | 2016 | 822 | 0.080 |
Why?
| | Microarray Analysis | 1 | 2011 | 116 | 0.080 |
Why?
| | Young Adult | 3 | 2025 | 14219 | 0.080 |
Why?
| | Chromosome Mapping | 1 | 2011 | 506 | 0.080 |
Why?
| | Genetic Loci | 1 | 2011 | 264 | 0.070 |
Why?
| | Blood Proteins | 1 | 2011 | 239 | 0.070 |
Why?
| | Pregnancy | 1 | 2022 | 7202 | 0.070 |
Why?
| | Biomarkers | 1 | 2020 | 4295 | 0.070 |
Why?
| | Blood Platelets | 1 | 2011 | 379 | 0.070 |
Why?
| | Nerve Tissue Proteins | 1 | 2011 | 591 | 0.060 |
Why?
| | Genetic Predisposition to Disease | 1 | 2014 | 2378 | 0.060 |
Why?
| | Risk Factors | 3 | 2025 | 10885 | 0.060 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2026 | 531 | 0.050 |
Why?
| | Adolescent Development | 1 | 2024 | 72 | 0.050 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2011 | 2158 | 0.050 |
Why?
| | Mutation | 1 | 2013 | 4075 | 0.050 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2026 | 779 | 0.040 |
Why?
| | Electronics | 1 | 2022 | 65 | 0.040 |
Why?
| | Adolescent Behavior | 1 | 2024 | 494 | 0.040 |
Why?
| | Phenotype | 2 | 2016 | 3155 | 0.030 |
Why?
| | Amish | 1 | 2016 | 7 | 0.030 |
Why?
| | Indiana | 1 | 2016 | 38 | 0.030 |
Why?
| | Wisconsin | 1 | 2016 | 99 | 0.030 |
Why?
| | Point Mutation | 1 | 2016 | 240 | 0.030 |
Why?
| | Molecular Docking Simulation | 1 | 2015 | 119 | 0.030 |
Why?
| | Parents | 1 | 2023 | 1403 | 0.030 |
Why?
| | Prospective Studies | 1 | 2026 | 8057 | 0.020 |
Why?
| | Crystallography, X-Ray | 1 | 2015 | 486 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2026 | 3904 | 0.020 |
Why?
| | Mutation, Missense | 1 | 2015 | 335 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2015 | 855 | 0.020 |
Why?
| | HEK293 Cells | 1 | 2015 | 741 | 0.020 |
Why?
| | Brain | 1 | 2024 | 2947 | 0.020 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2011 | 157 | 0.020 |
Why?
| | Genes, Recessive | 1 | 2011 | 78 | 0.020 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2011 | 387 | 0.020 |
Why?
| | Homozygote | 1 | 2011 | 199 | 0.020 |
Why?
| | Sex Factors | 1 | 2016 | 2105 | 0.020 |
Why?
| | Genetic Linkage | 1 | 2011 | 272 | 0.020 |
Why?
| | Cluster Analysis | 1 | 2011 | 500 | 0.020 |
Why?
| | Protein Binding | 1 | 2015 | 2238 | 0.020 |
Why?
| | Age Factors | 1 | 2016 | 3342 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 2011 | 777 | 0.020 |
Why?
| | Base Sequence | 1 | 2011 | 2170 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2011 | 2129 | 0.020 |
Why?
| | Phylogeny | 1 | 2011 | 917 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2011 | 2883 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2016 | 5905 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2016 | 6447 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2016 | 8333 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2016 | 6066 | 0.010 |
Why?
| | Case-Control Studies | 1 | 2011 | 3623 | 0.010 |
Why?
| | Infant | 1 | 2016 | 10077 | 0.010 |
Why?
| | Child, Preschool | 1 | 2016 | 11853 | 0.010 |
Why?
| | Aged | 1 | 2016 | 26153 | 0.010 |
Why?
| | Middle Aged | 1 | 2016 | 36215 | 0.010 |
Why?
|
|
Hinckley's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|